Suppr超能文献

先天性肌无力综合征:7例西西里患者的临床及分子报告

Congenital myasthenic syndromes: Clinical and molecular report on 7 Sicilian patients.

作者信息

Pavone Piero, Polizzi Agata, Longo Maria Roberta, Romano Katia, Vecchio Michele, Praticò Andrea D, Falsaperla Raffaele

机构信息

Department of Pediatric and Pediatric Neurology, Azienda Ospedaliera Universitaria OVE-Policlinico, University of Catania, Catania, Italy.

出版信息

J Pediatr Neurosci. 2013 Jan;8(1):19-21. doi: 10.4103/1817-1745.111416.

Abstract

BACKGROUND

Congenital myasthenic syndromes (CMS) are a heterogeneous group of diseases involving neuromuscular transmission. The classification of these syndromes is based on the localization of the defect (pre-synaptic, post-synaptic, and neuromuscular junction) and on the molecular analysis.

AIM

To report on a series of 7 patients affected by post-synaptic CMS.

PATIENTS AND METHODS

We examined sex, familiarity, age of onset, clinical symptoms, and response to tensilon test, patellar and pupillary reflexes, presence of cranial nerve involvement, Gowers' sign, presence of ptosis, grade of muscular weakness, and response to the treatment and gene deletions.

RESULTS

Ptosis, muscular hypotonia, and light variability in muscular weakness were the main clinical signs. Cholinergic receptor, nicotinic, epsilon (CHRNE) gene mutations were mainly reported.

CONCLUSIONS

The study points out that the clinical and molecular pattern reported in our patients do not differentiate from the data reported in the literature. Treatment with pyridostigmine and modulation of the therapy allows a good quality of life.

摘要

背景

先天性肌无力综合征(CMS)是一组涉及神经肌肉传递的异质性疾病。这些综合征的分类基于缺陷的定位(突触前、突触后和神经肌肉接头)以及分子分析。

目的

报告一系列7例受突触后CMS影响的患者。

患者与方法

我们检查了性别、家族史、发病年龄、临床症状、对腾喜龙试验的反应、髌反射和瞳孔反射、是否存在颅神经受累、Gowers征、是否存在上睑下垂、肌无力程度以及对治疗的反应和基因缺失情况。

结果

上睑下垂、肌张力减退和肌无力轻度波动是主要临床体征。主要报告了胆碱能受体、烟碱型、ε(CHRNE)基因突变。

结论

该研究指出,我们患者中报告的临床和分子模式与文献中报告的数据无差异。吡啶斯的明治疗和治疗调整可使生活质量良好。

相似文献

1
Congenital myasthenic syndromes: Clinical and molecular report on 7 Sicilian patients.
J Pediatr Neurosci. 2013 Jan;8(1):19-21. doi: 10.4103/1817-1745.111416.
3
A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome.
Child Neurol Open. 2023 Nov 28;10:2329048X231216432. doi: 10.1177/2329048X231216432. eCollection 2023 Jan-Dec.
4
Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families.
Rev Neurol (Paris). 2025 Jan-Feb;181(1-2):79-84. doi: 10.1016/j.neurol.2024.09.007. Epub 2024 Oct 7.
5
[Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Rev Neurol (Paris). 2004 Feb;160(2):163-76. doi: 10.1016/s0035-3787(04)70887-5.
6
Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes-A Retrospective Single Centre Cohort Study.
Front Hum Neurosci. 2020 Dec 7;14:560860. doi: 10.3389/fnhum.2020.560860. eCollection 2020.
7
A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
Neurology. 1999 Oct 22;53(7):1564-9. doi: 10.1212/wnl.53.7.1564.
8
Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
J Neuroimmunol. 2008 Sep 15;201-202:6-12. doi: 10.1016/j.jneuroim.2008.06.026. Epub 2008 Aug 15.
9
Homozygous Duplication in the in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up.
Biomedicines. 2023 Nov 6;11(11):2983. doi: 10.3390/biomedicines11112983.
10

引用本文的文献

本文引用的文献

1
Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.
J Med Genet. 2010 Dec;47(12):795-6. doi: 10.1136/jmg.2010.081034. Epub 2010 Oct 7.
2
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.
Neurology. 2009 Jul 21;73(3):228-35. doi: 10.1212/WNL.0b013e3181ae7cbc.
3
Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children.
Dev Med Child Neurol. 2008 May;50(5):328-33. doi: 10.1111/j.1469-8749.2008.02038.x. Epub 2008 Feb 28.
4
The therapy of congenital myasthenic syndromes.
Neurotherapeutics. 2007 Apr;4(2):252-7. doi: 10.1016/j.nurt.2007.01.001.
5
126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands.
Neuromuscul Disord. 2005 Jul;15(7):498-512. doi: 10.1016/j.nmd.2005.05.001.
6
Current understanding of congenital myasthenic syndromes.
Curr Opin Pharmacol. 2005 Jun;5(3):308-21. doi: 10.1016/j.coph.2004.12.007.
7
Congenital myasthenic syndromes.
Semin Neurol. 2004 Mar;24(1):111-23. doi: 10.1055/s-2004-829592.
9
Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Neurology. 2003 Jun 10;60(11):1805-10. doi: 10.1212/01.wnl.0000072262.14931.80.
10
Congenital myasthenic syndromes: recent advances.
Arch Neurol. 1999 Feb;56(2):163-7. doi: 10.1001/archneur.56.2.163.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验